**7.10 Autoimplantation therapy**

Autowart inoculation by means of homologous autoimplantation helping to induce specific cell-mediated immunity has been proposed as a treatment option for recalcitrant, extensive and genital wart [190]. About 83 patients with all types of wart lesions were included in a study. At 16 weeks of therapy, 69.5% of patients recovered completely, and more than 75% improvement occurred in another 8.5% patients. No significant complication was documented. There was no recurrence within study period [191]. Another study also had noticed 73.3% total clearance of warts, with a majority of them (91%) within 2 months [190]. Inoculation site infection and postinflammatory hyperpigmentation and hypopigmentation are the side effects.
